How Receptive Are You?
For in vitro fertilization (IVF) to be successful, the uterus must receive the embryo during the implantation phase. The window of implantation is small. Missing this window can lead to failed IVF cycles. Endometrial receptivity analysis (ERA) is an effective diagnostic tool for IVF patients. With ERA, fertility clinics can estimate the ideal time for embryo implantation, increasing success rates. ERA testing becomes an invaluable tool when assessing the reasons for IVF failure. This additional step can help fertility teams create a better uterine environment for hopeful parents.

Why IVF fails with healthy embryos
IVF requires the combination of eggs and sperm to create embryos. Some couples have healthy embryos but still have failed IVF cycles. The average IVF cycle has a 40% success rate, which can decline due to page and genetic issues. Failures can occur not due to embryo health, but the timing of the transfer. Studies suggest that up to 30% of women may have a displaced window of implantation. Fertility specialists need to test the uterine lining, and then create a plan to help create a more receptive uterine environment. Sometimes, increasing success rates involves improving receptivity timing. Embryos are transferred outside the optimal window and are less likely to implant.
How ERA testing works
ERA testing is a simple yet effective step, which is not necessary for all cases, but essential in delicate circumstances. Fertility teams perform ERA by taking a small tissue sample from the uterine lining during a mock cycle. This cycle mimics the timing of a real embryo transfer. Along with the sample comes a mixture of clinical and imaging techniques. Transvaginal ultrasound helps gauge factors like thickness, volume, and blood flow. A scoring system determines the best times for pregnancy. The sample is also analyzed using gene expression profiling, called the endometrial receptivity array (ERA), to assess the receptivity of the endometrium. This allows specialists to determine whether the uterus is receptive, pre-receptive, or post-receptive at the expected time of transfer.
Who benefits from ERA?
ERA testing helps to make a customized transfer plan, increasing the chances of successful implantation. For women with recurrent implantation failure or unexplained IVF failure, ERA may provide new insight. Some women have a known thin endometrial lining before starting IVF. Testing can determine the best window for implantation in these sensitive cases. Women with irregular menstrual cycles or hormone imbalances should get ERA testing before the first IVF cycle. While testing takes additional time, couples can potentially save time and money long-term by having fewer IVF cycles.
How clinics customize uterine environments
Fertility clinics can help improve the uterine environment, thereby increasing implantation rates. The ERA test will determine the best times and ideal treatment needed. Tailoring timing helps to improve pregnancy rates. Hormone replacement therapy (HRT) involving adequate levels of estrogen and progesterone prepares and maintains the uterine lining for optimal transfer. Studies show that stem cell therapy, known as regenerative medicine, is showing promise in healing and improving uterine receptivity. Other options include surgical intervention and advanced imaging techniques.
Moving forward with confidence
Individuals with multiple failed IVF cycles despite having healthy embryos should lean on ERA testing. If there are no other clear reasons for IVF failure, this is a helpful step. Ensuring there is an optimal window for implantation boosts pregnancy rates. Fertility clinics can only verify endometrial receptivity through rigorous testing. From there, treatment and medication can help create a more suitable environment. ERA offers promising insights but is not a universal solution. Even with treatment, some women have uterine lining challenges that may require additional options like gestational surrogacy. Work with the fertility team as ERA can make all the difference in achieving pregnancy.

